CLASS II Drug recall · Reported 4 Aug 2021 · FDA Enforcement Report
Azelaic Acid 0+% Micro recalled by API Solutions
API Solutions is recalling Azelaic Acid 0+% Micro, distributed in Alabama, Arizona, Colorado, Florida, Virginia. The recall was initiated on 15 Jul 2021 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0696-2021
- FDA event ID
- 88289
- Recalling firm
- API Solutions, Daphne, AL
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 15 Jul 2021
- FDA classified
- 28 Jul 2021
- Reported
- 4 Aug 2021
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
Timeline
| 15 Jul 2021 | Recall initiated by company | |
| 28 Jul 2021 | Classified by FDA | +13 days |
| 4 Aug 2021 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP Deviations
Product as listed by the FDA
Azelaic Acid 99.0+% Micro 500 Grams, Distributed By: A.P.I. Solutions Daphne Alabama Manufactured by: Yicheng Chemicals Corp. China Distributed by: Syntec Pharma Corp New York
Where it was distributed
AL, AZ, CO, FL, VA
Questions about this recall
Is Azelaic Acid 0+% Micro recalled?
Yes. API Solutions recalled Azelaic Acid 0+% Micro on 15 Jul 2021. The recall is Class II and its status is Terminated. Recall number D-0696-2021.
Why was it recalled?
cGMP Deviations
Which lots are affected?
Lot #: AZA181105, Exp 11/09/2021
Where was it sold?
AL, AZ, CO, FL, VA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from API Solutions
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Estriol USP41 Micro recalled by API Solutions | API Solutions | Manufacturing (CGMP) Deviations | 5 states |